Management Forum Logo

Presented by
Management Forum

Cosmetovigilance Training Course

An Essential Overview

This course will provide a comprehensive overview of cosmetogivilance in Europe, the USA and the Rest of the World (ROW). It will provide key guidance for manufacturers and distributors on how to comply with the regulatory requirements, and will be valuable for pharmaceutical and medical device companies looking to access the cosmetic market.

18-19 June 2026
+ 8-9 December 2026 »

from £1299

Need help?  Enrol/reserve

Course overview

The regulations for cosmetic products worldwide have been in place for nearly 50 years and continue to evolve and expand across different regions. Historically, cosmetics were not required to undergo testing in the same way as medicinal products, largely due to the perceived minimal effect or ‘risk’ to the consumer. The same was true for safety reporting.

Over time, this position has changed significantly. The identification and analysis of adverse reactions, known as Serious Undesirable Effects (SUEs), associated with cosmetic products was once largely driven by industry initiatives. Today, however, the responsibility sits firmly with manufacturers to ensure products and ingredients are safe before they reach the market. In addition, they must actively collect and assess reports of undesirable effects in a manner similar to routine pharmacovigilance within the pharmaceutical sector, as well as produce safety summaries for their products.

Regulatory expectations also vary internationally, with different requirements across countries for areas such as the collation of data within the Product Information File (PIF), safety reviews, causality assessments, reporting obligations, and other legislative considerations.

This course delivers a comprehensive overview of Cosmetovigilance across Europe, the USA, and the Rest of the World (ROW). It explores the relevant legislation, regulatory requirements, reporting obligations, the role of the Responsible Person, as well as borderline products and promotional claims.

Overall, the course provides essential guidance for manufacturers and distributors seeking to understand and comply with global regulatory requirements. It is also highly valuable for pharmaceutical and medical device companies looking to expand into the cosmetic market.

This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.

Benefits of attending

  • Hear the differences in global regulatory requirements across regions
  • Understand causality assessments within Cosmetovigilance and how they are applied
  • Learn how to manage the Product Information File (PIF) effectively and in line with regulations
  • Gain insight into safety signal analysis and its importance in product safety monitoring
  • Understand the role and responsibilities of the Responsible Person in Cosmetovigilance compliance
  • Discuss borderline products and how they are classified as cosmetics
  • Become aware of advertising and promotional regulations for cosmetic products
  • Learn about the sanctions that Regulatory Agencies can impose with non-compliance

Who should attend

  • Customer call personnel/product safety/product complaints
  • Undesirable effect assessors
  • R&D
  • Regulatory affairs professionals
  • Quality control and assurance
  • Responsible persons

Popular with...

This course has proven particularly popular among our customers in these roles:

  • Medical Affairs Manager
  • Regulatory Manager
  • Senior Manager Pharmacovigilance Epidemiology & Risk Management

Enrol/reserve

This course will cover:

An introduction to cosmetovigilance

  • New EU Legislation
  • USA and rest of world reporting
  • What needs to be reported
  • Data capture techniques

Causality assessments in cosmetovigilance

  • Legal basis for causality assessments
  • Types of causality
  • Where causality assessments appear
  • Determining causality

The Product Information File (PIF)

  • Availability and purpose
  • Composition
  • Maintenance and updates

Safety signal analysis – what is a signal?

  • What is a signal?
  • Where to look for signals
    • Literature
    • Individual reports
    • Pre-Clinical findings

Safety signal analysis –the signal and actions?

  • Trending over time
  • Quality of the reports
  • Potential signals and their handling – communication
    • Regulators
    • Public

Borderline products & cosmetics

  • What is a borderline product?
  • What does this mean for cosmetics
  • Safety reporting for a product that is device and cosmetic?

Annual product safety report

  • Product safety information
  • Subsections for the safety information
  • Product safety assessment
  • Information for the safety assessment

The regulators perspective for cosmetovigilance

  • Regulatory inspections for cosmetics
    • USA
    • Europe
    • ROW

The Responsible Person for cosmetovigilance

  • The role of the Responsible Person
  • Qualifications and expectations from the regulatory agencies

The practical role of the Responsible Person for cosmetovigilance

  • The role of the Responsible Person with:
    •  Ingredients, labelling and claims compliance
    •  Configuration and custody of the Cosmetic Product Information File (PIF)
    •  Configuration of the Cosmetic Product Safety Report (CPSR)

The practical role of the Responsible Person for cosmetovigilance (continued)

  • The role of the Responsible Person with:
    • Product notification on the Cosmetic Products Notification Portal (CPNP)
    • Post-market surveillance 
    • Review of Nanomaterials and Carcinogenic, Mutagenic and Reprotoxic (CMR) substances

Promotional claims for cosmetics

  • The regulations for advertising cosmetics
  • Medical claims
  • Penalties for false advertising

Enrol/reserve

Graeme Ladds
PharSafer Associates Ltd

Graeme Ladds, Director of PharSafer, has over 30 years’ experience in the pharmaceutical industry. He began his career in 1989 at Ashbourne Pharmaceuticals as Head of Drug Safety & Medical Information, before going on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.

He later founded his consultancy and specialist CRO, PharSafer Associates Ltd, where he has supported companies in establishing pharmacovigilance systems, conducting audits across Europe and the USA, developing SOPs, acting as a QP, and supporting regulatory inspections.

Since 1994, Graeme has also been involved in the monitoring of medical devices, including drug–device combinations, structural devices and electrical medical devices. His experience spans clinical trials and global device vigilance, alongside pharmacovigilance activities across both clinical development and post-marketing phases.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

18-19 June 2026

Live online

09:30-16:45 UK (London) (UTC+01)
10:30-17:45 Paris (UTC+02)
04:30-11:45 New York (UTC-04)
Timings may be different for each day
Course code 16142

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 14 May

View basket 

 
Not ready to book yet?

for 7 days, no obligation

8-9 December 2026

Live online

09:30-16:45 UK (London) (UTC+00)
10:30-17:45 Paris (UTC+01)
04:30-11:45 New York (UTC-05)
Timings may be different for each day
Course code 16418

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 03 Nov

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

United Kingdom

  • Actavis UK Ltd
  • Aris Global UK Ltd
  • Boots
  • Boots Uk Ltd
  • Dermal Laboratories Ltd
  • Oat Services Ltd
  • Potter & Moore Innovations Ltd
  • PPD
  • Procter & Gamble

Denmark

  • Billev Pharma
  • Jacobsen Pharma & MedTech Advice A/S

Sweden

  • Bioglan AB
  • H & M Hennes & Mauritz GBC AB

Germany

  • Pharmalex GmbH

Netherlands

  • Teva Nederland

Saudi Arabia

  • Saudi Food and Drug Authority

Slovak Republic

  • Ewopharma international

Switzerland

  • TEOXANE SA

Enrol/reserve

Run Cosmetovigilance Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 1,000
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our team to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Harry Altamont

Harry
ALTAMONT

Aleksandra Beer

Aleksandra
BEER

+44 (0)20 7749 4749

inhouse@ipiacademy.com